Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultralife (ULBI) Other financing activities (2017 - 2024)

Ultralife has reported Other financing activities over the past 10 years, most recently at $1.3 million for Q4 2024.

  • Quarterly results put Other financing activities at $1.3 million for Q4 2024, changed N/A from a year ago — trailing twelve months through Dec 2025 was $1.4 million (up 1.83% YoY), and the annual figure for FY2025 was $24000.0, down 98.28%.
  • Other financing activities for Q4 2024 was $1.3 million at Ultralife, up from $68000.0 in the prior quarter.
  • Over the last five years, Other financing activities for ULBI hit a ceiling of $1.3 million in Q4 2024 and a floor of -$25000.0 in Q3 2023.
  • Median Other financing activities over the past 4 years was $7000.0 (2020), compared with a mean of $229000.0.
  • Biggest five-year swings in Other financing activities: fell 12.5% in 2020 and later surged 372.0% in 2024.
  • Ultralife's Other financing activities stood at -$7000.0 in 2020, then skyrocketed by 200.0% to $7000.0 in 2021, then plummeted by 457.14% to -$25000.0 in 2023, then soared by 5396.0% to $1.3 million in 2024.
  • The last three reported values for Other financing activities were $1.3 million (Q4 2024), $68000.0 (Q3 2024), and -$25000.0 (Q3 2023) per Business Quant data.